ArticleCurrent infectious disease reports2012
Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.
Article in Current infectious disease reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 83 citations in OpenAlex.
- Imaging findings of Balamuthia mandrillaris amoebic encephalitis in 2 cases with different prognosis and literature review.BMC neurology · 2025Review
- Fatal amoebic meningoencephalitis caused byFrontiers in veterinary science · 2025Article
- 18F-FDG PET/CT findings in fatalRadiology case reports · 2024Article
- Isolation and habitat analysis of Balamuthia mandrillaris from soil.Parasitology research · 2024Article
- Application of ventriculoscopy in granulomatous amoebic encephalitis: a case report in China and literature review.Frontiers in medicine · 2024Article
- Mitochondrial genome diversity ofFrontiers in microbiology · 2023Article
- Pathogenic free-living amoebic encephalitis from 48 cases in China: A systematic review.Frontiers in neurology · 2023Review
- Distribution and Current State of Molecular Genetic Characterization in Pathogenic Free-Living Amoebae.Pathogens (Basel, Switzerland) · 2022Review
- Balamuthia mandrillaris trophozoites ingest human neuronal cells via a trogocytosis-independent mechanism.Parasites & vectors · 2022Article
- Balamuthia mandrillaris brain infection: a rare cause of a ring-enhancing central nervous system lesion. Illustrative case.Journal of neurosurgery. Case lessons · 2022Article
- Opportunistic free-living amoebal pathogens.Pathogens and global health · 2022Article
- Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease.Frontiers of medicine · 2021Review
- Article
- Encephalomyelitis Caused byFrontiers in immunology · 2021Article
- Article
- Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl.Emerging microbes & infections · 2020Article
- Identification of T3 and T4 Genotypes of Acanthamoeba sp. in Dust Samples Isolated from Air Conditioning Equipment of Public Hospital of Ituiutaba-MG.Current microbiology · 2020Article
- Acanthamoeba spp. and Balamuthia mandrillaris leading to fatal granulomatous amebic encephalitis.Forensic science, medicine, and pathology · 2020Article
- Emerging infections: mimickers of common patterns seen in dermatopathology.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020Review
- The Epidemiology and Clinical Features of Balamuthia mandrillaris Disease in the United States, 1974-2016.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Balamuthia mandrillaris is a free living amoeba that can be isolated from soil. It is an emerging pathogen causing skin lesions as well as CNS involvement with a fatal outcome if untreated. The infection has been described more commonly in inmunocompetent individuals, mostly males, many children, and with a predilection for population with Hispanic background in cases occurring in the United States. Except for Africa, all continents have reported the disease, although a majority of cases are seen in North and South America. In published reported cases from North America, most patients will debut with neurological symptoms, where as in countries like Peru, a skin lesion will precede other symptoms. The classical skin lesion is a plaque, mostly located on face or knee. Diagnosis requires a high level of suspicion. Therapeutic strategies require a multidrug approach, than includes at least one amebicidal drug, and prolonged periods of treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.